A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart

Clinical trial NCT04256629 · COMPLETED

Trial details

NCT number: NCT04256629
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers (Intended Indication: Chronic Kidney Disease)

Start date: 2020-03-03
Primary completion: 2020-08-21
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.